TECH
- Bio-Techne Corporation
()
Overview
Company Summary
Bio-Techne Corporation, also known as TECH on the stock market, is a leading provider of life sciences tools and solutions. The company operates in two primary segments: Biotechnology and Diagnostics.
In the Biotechnology segment, Bio-Techne focuses on developing and manufacturing innovative proteins, antibodies, cytokines, and other reagents used in scientific research, drug discovery, and bioprocessing applications. These products serve various fields, including cancer research, stem cell research, immunology, and neuroscience. Bio-Techne's products enable scientists and researchers to study and understand the complexities of biological processes and diseases.
The Diagnostics segment is devoted to creating innovative diagnostic test kits and reagents used in clinical laboratories. These products target applications such as cancer diagnostics, cardiovascular diseases, infectious diseases, and prenatal screening. Bio-Techne's diagnostic solutions assist healthcare professionals in making accurate diagnoses and informing treatment decisions to improve patient outcomes.
In addition to its core segments, Bio-Techne provides several specialized services and technologies, including Novus Biologicals, R&D Systems, Tocris Bioscience, ProteinSimple, and Exosome Diagnostics. These brands offer a wide range of resources, tools, and services that complement the company's core product offerings.
Overall, Bio-Techne Corporation plays a critical role in advancing scientific research and healthcare through its offerings in biotechnology and diagnostics. By providing scientists, researchers, and healthcare professionals with cutting-edge tools and solutions, the company contributes to progress in understanding diseases, developing novel therapies, and improving patient care.